Institute Happenings UH Researcher Joins $3.2 Million Effort to Develop Promising New Breast Cancer Treatment Research Targets Deadly Triple-negative Breast CancerUH Newsroom Tam Elected Fellow of American Academy of Microbiology UHCOP Professor Joins Class of 2026 Recognized for Advancing Microbial ScienceCollege of Pharmacy UH Cardiac Researcher Develops Breakthrough Advancement in Battling Pediatric Heart Disease Identifies New Cause of and Partial Fix for a Spongy HeartUH Newsroom DDI Affiliate Receives $900,000 CPRIT Grant to Develop Nanodrug That Boosts Immune System to Fight Cancer Drug Could Offer Improved Survival for Patients with Pancreatic and Lung CancersUH Newsroom DDI Director Receives Nearly $1M to Advance Lupus Diagnosis and Treatment Federally Funded Study Will Explore a Cancer-linked Enzyme’s Role in LupusUH Newsroom Five Innovative Projects Receive 2025 Seed Grants DDI has awarded 2025 Seed Grants to research teams advancing innovative drug discovery. This year’s… New Cancer Biomarker Facility to be Housed at UH Drug Discovery Institute UH Receives $3M from CPRIT to set up a Cancer Immunotherapy Biomarker Core.University of Houston Pathways to Impactful Medicines The UH Drug Discovery Institute hosts Sharath Hegde of Congruence Therapeutics. Lipid Engineering to Create New Therapeutics and Other Products The UH Drug Discovery Institute hosts Dan Monticello of GlycosBio. Discovery and Optimization of Small Molecule Drug Leads and Probes The UH Drug Discovery Institute hosts John Buolamwini of Rosalind Franklin University. Immunological Memory in Weight Cycling Heather Caslin poses the question: is weight loss always good? Optimizing Biologics Development through Computational Modeling David Roush, distinguished scientist at Merck, presents his research to the Drug Discovery Institute… Pagination Page 1 Page 2 Next page Next › Last page Last »
